Anzeige
Mehr »
Login
Montag, 31.03.2025 Börsentäglich über 12.000 News von 695 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QCJL | ISIN: US8776191061 | Ticker-Symbol:
NASDAQ
31.03.25
21:48 Uhr
1,375 US-Dollar
-0,520
-27,44 %
1-Jahres-Chart
TAYSHA GENE THERAPIES INC Chart 1 Jahr
5-Tage-Chart
TAYSHA GENE THERAPIES INC 5-Tage-Chart

Aktuelle News zur TAYSHA GENE THERAPIES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
07.03.Taysha Gene Therapies, Inc.: Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)134DALLAS, March 07, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) ("Taysha" or the "Company"), a clinical-stage biotechnology company focused on advancing adeno-associated virus...
► Artikel lesen
26.02.Taysha Gene Therapies GAAP EPS of -$0.36 beats by $0.02, revenue of $8.33M beats by $0.08M1
26.02.Taysha Gene Therapies, Inc.: Taysha Gene Therapies Reports Full-Year 2024 Financial Results and Provides Corporate Update439High dose and low dose of TSHA-102 continue to be generally well tolerated with no treatment-related SAEs or DLTs in all pediatric, adolescent and adult patients treated (high dose, n=6; low dose...
► Artikel lesen
26.02.Taysha Gene Therapies, Inc. - 10-K, Annual Report-
26.02.Taysha Gene Therapies, Inc. - 8-K, Current Report-
25.02.Taysha Gene Therapies FY 2024 Earnings Preview1
TAYSHA GENE THERAPIES Aktie jetzt für 0€ handeln
07.02.Taysha Gene Therapies, Inc.: Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)124DALLAS, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based...
► Artikel lesen
07.01.Taysha Gene Therapies, Inc. - S-8, Securities to be offered to employees in employee benefit plans-
06.01.Assessing Taysha Gene Therapies: Insights From 8 Financial Analysts2
03.01.Taysha Gene Therapies, Inc.: Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)156DALLAS, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based...
► Artikel lesen
13.12.24Taysha Gene Therapies files for $300M mixed shelf offering2
06.12.24Taysha Gene Therapies, Inc.: Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)176DALLAS, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based...
► Artikel lesen
14.11.24Advance Auto Parts Posts Weak Results, Joins Harrow, Taysha Gene Therapies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session6
13.11.24Taysha Gene Therapies GAAP EPS of $1.78 beats by $1.87, revenue of $1.78M beats by $0.13M8
13.11.24Taysha Gene Therapies, Inc. - 10-Q, Quarterly Report-
12.11.24Preview: Taysha Gene Therapies' Earnings3
12.11.24JMP Securities Reaffirms "Market Outperform" Rating for Taysha Gene Therapies (NASDAQ:TSHA)7
12.11.24Pre-market Movers: BTC Digital, XBP Europe, Neurogene, 1847 Holdings, Taysha Gene Therapies665OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.00 A.M. ET).In the Green BTC Digital Ltd. (BTCT) is up over 78% at $4.50. XBP...
► Artikel lesen
09.11.24Taysha Gene Therapies Inc Aktie: Unternehmensstrategien und deren Umsetzung700Die Aktie von Taysha Gene Therapies Inc, einem Unternehmen für Gentherapien, verzeichnete am 9. November 2024 einen bemerkenswerten Kursanstieg von 5,63% auf 1,50 USD. Dieser Zuwachs ist besonders erwähnenswert...
► Artikel lesen
05.11.24Taysha Gene Therapies reiterates stock target with positive outlook5
Seite:  Weiter >>
37 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1